1990
DOI: 10.1016/0190-9622(90)70218-7
|View full text |Cite
|
Sign up to set email alerts
|

Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
40
0
2

Year Published

1992
1992
2019
2019

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(42 citation statements)
references
References 7 publications
0
40
0
2
Order By: Relevance
“…Reported cases of XD usually follow a chronic course which lasts for years or decades [2,7,10,22,24]. Skin lesions usually reach a peak of severity after 1-2 years.…”
Section: Discussionmentioning
confidence: 99%
“…Reported cases of XD usually follow a chronic course which lasts for years or decades [2,7,10,22,24]. Skin lesions usually reach a peak of severity after 1-2 years.…”
Section: Discussionmentioning
confidence: 99%
“…Low-fat diet [3,8], surgical excision [3,4,20], electrocoagulation [20], cryotherapy [8], radiation [3,21], glucocorticoids [22,23,24], anti-metabolites [21,24], anti-cancer drugs [4], lipid-lowering agents [4,17,25], or combinations of these therapies have been tried. However, most XD patients do not respond to any form of therapy and their disease either remains stable or becomes progressive.…”
Section: Discussionmentioning
confidence: 99%
“…XD usually is a self-limiting and benign disorder [3], but a patient with similar skin lesions, diabetes insipidus and multiple cerebral lesions [2] died 4 years after developing disseminated CNS symptoms. As therapy is similar to MS, but not identical, patients with MS and a hypothalamic syndrome should be evaluated for histiocytosis.…”
mentioning
confidence: 99%
“…Our patient's prednisolone dependency also appeared untypical for MS. Autopsy eventually revealed that our patient had suffered from MS and XD. This hardly is a chance association, taken the rarity of cerebral histiocytosis and the frequency of reported concurrent disseminated encephalomyelopathies, relapsing [2,6] or demyelinating [4][5][6].…”
mentioning
confidence: 99%